ad image

Antibody-Drug Conjugate

1 / 2
Rising Interest in Radioconjugate Therapies
Radioconjugates

Rising Interest in Radioconjugate Therapies

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-02-25-NI-05Feb 25, 2025
Nona Biosciences
Announcement

Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene

Nona Biosciences

PR-01-25-NI-02Jan 03, 2025
World ADC
Announcement

Celebrating More than a Decade of Excellence at the World ADC Awards – Winners Announcement

World ADC

PR-10-24-NI-77Nov 08, 2024
World ADC
ADC

World ADC San Diego Celebrates 15th Anniversary With Industry-Leading Agenda

World ADC

PR-10-24-NI-37Oct 10, 2024
Reducing ADC Development Timelines with Integrated Development and Manufacturing Services
Antibody-Drug Conjugates

Reducing ADC Development Timelines with Integrated Development and Manufacturing Services

Thomas Rohrer

Samsung Biologics

PAO-11-23-CL-01Nov 13, 2023
CRB
Digitalization, AI, and Automation

Digitalization, AI, and Automation Lead Pack of Advances Fueling Life Sciences Industry Growth, New CRB Report Finds

CRB

PR-M10-23-05Oct 19, 2023
New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!
Biomanufacturing

New Name, Same Expertise: Goodwin Biotechnology is Becoming GBI!

Danielle Alvarez

Pharma's Almanac

PAO-11-022-CL-11Dec 05, 2022
Vaccines Present a Novel Strategy for Opioid Overdose Prevention
Opioid Conjugate Vaccines

Vaccines Present a Novel Strategy for Opioid Overdose Prevention

Muctarr Sesay, Ph.D.

GBI

PAO-10-022-CL-07Oct 31, 2022
Improving the Therapeutic Index of ADCs with a Peptide Linker Technology
ADCS

Improving the Therapeutic Index of ADCs with a Peptide Linker Technology

Philipp Spycher

Araris Biotech AG

PAO-07-022-CL-01Jul 07, 2022
Accelerating ADC Development with Advanced Payload Intermediates
Antibody-Drug Conjugates

Accelerating ADC Development with Advanced Payload Intermediates

David Goeddel, Ph.D.

MilliporeSigma

PAO-06-21-CL-11Jun 24, 2021
Preparing for the ADC Explosion with End-to-End Support
Antibody–Drug Conjugates

Preparing for the ADC Explosion with End-to-End Support

Jyothi Swamy, Ph.D.; Elizabeth McKee

MilliporeSigma

PAP-Q4-20-CL-014Dec 09, 2020
MilliporeSigma
Expansion

MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion

MilliporeSigma

PR-M09-20-NI-14Sep 11, 2020
AstraZeneca
Collaboration

AstraZeneca and Daiichi Sankyo Enter Collaboration to Develop and Commercialize New Antibody Drug Conjugate

AstraZeneca

PR-M07-20-NI-41Jul 27, 2020
Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life
Antibody–Drug Conjugates

Linking Novel Medicines to Patients with Hard-to-Treat Cancers for Improved Quality of Life

Loretta Itri, M.D., F.A.C.P.,; Usama Malik

Immunomedics

PAP-Q2-20-CL-012Jul 01, 2020
Fast-Tracking ADC Development and Commercialization
Antibody-Drug Conjugate

Fast-Tracking ADC Development and Commercialization

Matteo Piazza

PROVEO

PAP-Q4-19-CL-003Dec 06, 2019
Increasing the Potency of Antibody–Drug Conjugates
Antibody-Drug Conjugate

Increasing the Potency of Antibody–Drug Conjugates

Philipp Spycher

Araris Biotech AG

PAP-Q4-19-CL-008Dec 06, 2019
Araris Biotech AG
Financing

Araris Biotech AG Closes Seed Financing Round of CHF 2.5 Million

Araris Biotech AG

PR-M08-19-NI-057Aug 20, 2019
Genetech’s Antibody–Drug Conjugate Receives FDA Approval
FDA Approval

Genetech’s Antibody–Drug Conjugate Receives FDA Approval

Pharma's Almanac

PAO-M06-19-NI-010Jun 20, 2019
Integrating ADC Manufacturing for the Future
ADC

Integrating ADC Manufacturing for the Future

Mark Frigerio, Ph.D.; Juan Carlos Cordova, Ph.D.

Abzena

PAP-Q2-2019-CL-002May 24, 2019
Speeding up ADC Development With the Right Partner Organization
ADC

Speeding up ADC Development With the Right Partner Organization

Courtney Morgret, Ph.D.

AbbVie Contract Manufacturing

PAP-Q2-2019-CL-001May 24, 2019
1 / 2